Due to recent results from clinical intra-arterial treatment for acute ischemic stroke (IAT-AIS) trials such as the Interventional Management of Stroke (IMS III), IAT-AIS and the merit of revascularization have been contested.Even though intra-arterial treatment (IAT) has been shown to improve revascularization rates, a corresponding increase in go